amifampridine has been researched along with mlck peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, C; Landmesser, LT; Plattner, F; Polo-Parada, L | 1 |
1 other study(ies) available for amifampridine and mlck peptide
| Article | Year |
|---|---|
NCAM 180 acting via a conserved C-terminal domain and MLCK is essential for effective transmission with repetitive stimulation.
Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Animals; Animals, Newborn; Blotting, Western; Bungarotoxins; Computational Biology; Cysteamine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Heterocyclic Compounds, 4 or More Rings; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, Knockout; Models, Neurological; Myosins; Neural Cell Adhesion Molecules; Neuromuscular Junction; Oligopeptides; PC12 Cells; Peptide Fragments; Peptides; Potassium Channel Blockers; Protein Structure, Tertiary; Rats; Signal Transduction; Synaptic Transmission; Xenopus | 2005 |